- Three named ingredients
- Clinician review before prescribing
- Dedicated pigment-care option
Exact concentrations and treatment duration need individual confirmation.
Understand the prescription, the pigment concern and the plan around it. Twelve brands are reviewed with their different formulas, evidence limits and purchase routes kept clear.

Twelve brand profiles span prescribing services, a labeled drug, cysteamine and cosmetic comparisons. The five additions document Numbuzin, Dr. Melaxin, Caudalie, Eqqualberry and Obagi. CoreAge Rx has first commercial placement; this is not a clinical ranking.
Exact concentrations and treatment duration need individual confirmation.
The Spot Cream is marketed for melasma and other pigment concerns.
Patient-reported outcomes do not replace controlled comparative evidence.
Dark Spot Rx is a customized pigment treatment, with hydroquinone-free formulas also possible.
Not every formula contains hydroquinone; the brand name is not a fixed recipe.
A fixed three-drug cream with a specific short-term facial-melasma indication.
Not indicated for maintenance; the label has important population and use limits.
Studies of older 5% preparations are not automatically trials of today’s 7% formula.
Discoloration Defense publishes four highlighted ingredient percentages.
Appearance studies are not a head-to-head melasma treatment ranking.
Dark-spot marketing is not a diagnosis or a prescription treatment claim.
The No.5 ampoule joins this directory as a cosmetic comparison, with its powder-specific percentage and US refund restrictions made explicit.
No independently appraised melasma trial is claimed.
Picotonic’s niacinamide declaration, fragrance and order exclusions are reviewed without converting pigmentation marketing into a melasma-treatment claim.
The $42 reference price and clinical superiority are not independently established.
Vinoperfect’s laboratory comparison, volunteer summaries and purchase modes are kept distinct in a cosmetic brand profile.
The 62× claim is not a clinical melasma-performance multiplier.
The Original serum’s ingredient units and sold-out status are preserved, without importing a bundle price or a clinical melasma conclusion.
A separate product or bundle cannot fill the missing offer.
Clear Rx and Clear Fx are compared under their full names so hydroquinone, arbutin and seller-specific terms cannot be confused.
Similar family names do not establish interchangeable formulas or outcomes.
The named blend, current starting price and prescribing questions behind CoreAge Rx’s pigment cream.
A personalized pigment-treatment family whose exact prescription and renewal deserve a closer look.
A custom pigment treatment with several possible active ingredients and a specified 60-day supply.
Viniferine’s laboratory comparison, separate volunteer studies and a recurring purchase option require different readings. None establishes a universal melasma result.
Acerola water, niacinamide and a trace declared vitamin C derivative have different units and meanings. The Original serum’s sold-out listing does not establish a current purchase price.
Two similar Clear names lead to different formulations and purchase routes. Hydroquinone in the prescription product must not be assigned to the arbutin cosmetic.
An initial response, complete clearing and control after treatment are different outcomes. A triple-combination trial shows why the calendar belongs beside every melasma result.
Color measurements, clinical scores and sustained control use different clocks. Understanding those clocks helps place sunscreen findings beside short-term cream research.
A shared color does not mean two pigment concerns need the same cream.
A cream comparison is incomplete without the protection used around treatment.
The ingredient, formulation and treatment window belong in the same conversation.
Understand why trial concentration, comparator and outcome matter to a product review.
We read product pages, published research, and regulatory guidance. We explain the tradeoffs, distinguish marketing from evidence, and link the sources so you can look closer.
Read our methodology